Calcium + Vitamin D3 + Vitamin C + Vitamin E + Multimineral

Allopathic
Indications

Approved & Common Clinical Uses:

  • Osteoporosis & Osteopenia: For prevention and adjunctive treatment of age-related, postmenopausal, or corticosteroid-induced bone loss.
  • Calcium & Vitamin D Deficiency: In patients with inadequate dietary intake or increased physiological demand (e.g., pregnancy, adolescence, elderly).
  • General Nutritional Support: Multivitamin and mineral supplementation in patients with poor diet, malabsorption, or chronic illnesses.
  • Fracture Healing: Enhances bone regeneration and mineralization after orthopedic injury or surgery.
  • Immune System Support: Especially in individuals prone to infections, Vitamin C and E contribute antioxidant and immune-regulatory roles.
  • Chronic Fatigue or Debility: As part of multinutrient therapy in convalescent or debilitated patients.
Dosage & Administration

Adults:

  • Typical dose: 1 tablet once or twice daily (dose may vary based on product formulation).
  • Best taken with food to enhance absorption and reduce gastric irritation.

Pediatric Use:

  • Only formulations approved for pediatric use should be administered.
  • Dosage is weight and age-dependent (e.g., chewable tablets or syrups).
  • Pediatrician guidance required for dosing under 12 years.

Elderly:

  • No specific dose adjustment, but monitor calcium levels and renal function.
  • Increased vitamin D requirement is common in elderly patients.

Pregnant & Lactating Women:

  • Safe in recommended daily amounts. Dosing individualized based on dietary intake and prenatal needs.

Renal/Hepatic Impairment:

  • Caution in renal insufficiency due to risk of hypercalcemia and mineral imbalance.
  • Monitor serum calcium, phosphate, and vitamin D levels regularly.

Route of Administration:

  • Oral, with water, preferably after meals.

Duration:

  • Based on clinical need; can be used for short-term replenishment or long-term maintenance.
Mechanism of Action (MOA)

This combination works synergistically to support bone health, immune function, and antioxidant defense. Calcium serves as a vital component in bone mineralization and muscular function. Vitamin D3 (Cholecalciferol) enhances intestinal absorption of calcium and phosphate, facilitating bone growth and remodeling. Vitamin C (Ascorbic Acid) supports collagen synthesis and boosts immunity. Vitamin E (Tocopherol) acts as a lipid-soluble antioxidant, protecting cells from oxidative stress. Multiminerals such as magnesium, zinc, selenium, copper, and manganese participate in enzymatic functions, bone metabolism, antioxidant defense, and tissue repair.

Pharmacokinetics
  • Calcium: Absorption is ~20–30%, enhanced by vitamin D. Stored mainly in bones. Excreted via urine and feces.
  • Vitamin D3: Absorbed in the small intestine (fat-soluble), metabolized in the liver to 25(OH)D and then in the kidneys to active 1,25(OH)₂D₃. Half-life: ~15–20 days.
  • Vitamin C: Rapidly absorbed in the small intestine. Distributed widely in tissues. Metabolized in liver; excreted renally. Half-life: ~8–40 days (dose-dependent).
  • Vitamin E: Absorbed with dietary fat, transported via chylomicrons. Stored in adipose tissue. Excreted in bile and urine. Long half-life (~48–60 hours).
  • Minerals: Each has distinct absorption and excretion profiles—often affected by dietary factors, interactions, and individual bioavailability.
Pregnancy Category & Lactation
  • Pregnancy: All components are considered safe in recommended dietary allowances (RDA). Calcium and vitamin D are often supplemented during pregnancy to support fetal bone growth.
  • Lactation: Compatible with breastfeeding. Small amounts of vitamins and minerals are excreted in breast milk but are not harmful at physiological doses.
  • Caution: High doses may lead to hypercalcemia or vitamin D toxicity.
Therapeutic Class
  • Calcium Supplement with Vitamins and Minerals
  • Subclasses:
    • Bone Health Supplement
    • Antioxidant & Immune Support
    • Multivitamin-Multimineral Complex
Contraindications
  • Hypersensitivity to any component of the formulation
  • Hypercalcemia (e.g., due to hyperparathyroidism, vitamin D overdose)
  • Severe renal impairment or renal stones (nephrolithiasis)
  • Hypervitaminosis D
  • Hemochromatosis or other mineral overload disorders
Warnings & Precautions
  • Monitor serum calcium, phosphate, and vitamin D in patients on long-term therapy.
  • Use cautiously in patients with renal impairment, sarcoidosis, or malabsorption syndromes.
  • Avoid excessive supplementation from multiple sources to prevent hypervitaminosis.
  • Risk of kidney stones with high calcium or vitamin C intake.
  • May interfere with absorption of certain drugs (e.g., bisphosphonates, tetracyclines).
Side Effects

Common (≥1%):

  • Gastrointestinal: Nausea, bloating, constipation, flatulence, metallic taste
  • Musculoskeletal: Mild bone or muscle pain (initially)
  • Skin: Mild rash (hypersensitivity)

Less Common:

  • Hypercalcemia: Confusion, fatigue, arrhythmia, muscle weakness
  • Hypervitaminosis D: Nausea, vomiting, polyuria, kidney dysfunction

Rare:

  • Allergic reactions: Anaphylaxis, urticaria
  • Renal calculi (with chronic high-dose calcium)
Drug Interactions
  • Tetracyclines/Quinolones: Reduced absorption when taken with calcium—separate by ≥2 hours.
  • Thiazide Diuretics: Increased risk of hypercalcemia.
  • Iron & Zinc Supplements: Competitive absorption—space doses.
  • Corticosteroids: May impair calcium absorption.
  • Digitalis Glycosides (e.g., digoxin): Hypercalcemia can potentiate toxicity.
  • Antacids with aluminum/magnesium: May alter mineral absorption.

Enzyme Involvement: No significant CYP450-mediated interactions.

Recent Updates or Guidelines
  • Recent guideline updates from WHO and global nutrition authorities emphasize combination calcium and vitamin D as key in osteoporosis prevention, especially in postmenopausal women and elderly men.
  • Multivitamin-multimineral preparations continue to be recommended for individuals at nutritional risk, including those with chronic illness, aging population, or malabsorption.
  • No recent FDA safety warnings for this combination in standard OTC formulations.
Storage Conditions
  • Store below 25°C (77°F), in a cool and dry place.
  • Protect from light and excessive moisture.
  • Keep tightly closed in original container.
  • Do not freeze.
  • Keep out of reach of children.
  • For effervescent or chewable tablets: use immediately after opening blister or foil.